Health In Tech, Inc. HIT

Financials SIC 6411 - Insurance Agents, Brokers & Service NAICS Finance and Insurance › Insurance Carriers and Related Activities › Agencies, Brokerages, and Other Insurance Related Activities › Insurance Agencies and Brokerages derived Nasdaq

To change the non-transparent $5.3 trillion1 healthcare industry with innovation that removes friction and complexities with vertical integration, process simplification,

automation, and digitalization.

platform company, which offers a marketplace that improves processes in the healthcare industry through vertical integration, process

simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for

Last close 0.56 2026-10-23
Market cap $35.3M estimated share count
52-week range 0.50 - 3.11

Valuation FY2025 figures against the last close

P/S0.9x
P/E28.1x
P/FCF11.3x
EV/EBITDA—
Dividend yield—
Diluted EPS0.02

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022
Revenue $37.6M$19.6M$19.2M—
Cost of revenue $12.4M$4.1M$2.3M—
Gross profit $20.9M$15.4M$16.8M—
R&D $1.6M$2.8M$2.0M—
SG&A $13.7M$8.5M$8.1M—
Total operating expenses $19.4M$14.4M$13.5M—
Interest expense —$495.0K$495.0K—
Pre-tax income $1.7M$889.0K$3.4M—
Income tax $395.3K$218.5K$945.2K—
Net income $1.3M$670.5K$4.0M—
EPS, basic 0.020.01——
EPS, diluted 0.020.01——
Shares, diluted (wtd. avg.) 57.7M53.7M——

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022
Cash and equivalents $7.7M$7.8M$2.4M$1.5M
Receivables $756.3K$1.6M$2.2M—
Total current assets $16.2M$10.8M$6.9M—
Total assets $23.1M$15.8M$11.5M—
Accounts payable $4.2M$1.9M$2.6M—
Total current liabilities $5.2M$2.1M$4.8M—
Total liabilities $6.0M$2.6M$5.4M—
Retained earnings $5.2M$3.9M$3.3M—
Total equity $17.1M$13.2M$6.1M$1.4M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022
Operating cash flow $3.1M$2.2M$1.5M—
Depreciation and amortisation $900.6K$541.1K——
Stock-based compensation $1.6M$468.5K——
Investing cash flow -$3.1M-$836.8K-$1.9M—
Financing cash flow -$187.4K$4.1M$1.3M—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-034211.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 10M 20M 30M 40M Revenue, FY2023: 19.2M Gross profit, FY2023: 16.8M Net income, FY2023: 4M Revenue, FY2024: 19.6M Gross profit, FY2024: 15.4M Net income, FY2024: 670.5K Revenue, FY2025: 37.6M Gross profit, FY2025: 20.9M Net income, FY2025: 1.3M FY2022 FY2023 FY2024 FY2025
Fiscal year FY2022FY2023FY2024FY2025
Revenue — $19.2M $19.6M $37.6M
Gross profit — $16.8M $15.4M $20.9M
Net income — $4.0M $670.5K $1.3M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Regulation FD disclosure Item 7.01
  • Material agreement signed Item 1.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 6411

TickerCompanyMarket capP/ERevenue growth
MRSH MARSH & MCLENNAN COMPANIES, INC. $94.24B 23.4x 10.3%
AJG Arthur J. Gallagher & Co. $68.70B 46.7x 20.7%
AON Aon plc $64.38B 17.8x 9.4%
WTW WILLIS TOWERS WATSON PLC $30.18B 20.0x -2.3%
BRO BROWN & BROWN, INC. $24.42B 23.1x 22.8%
EQH Equitable Holdings, Inc. $14.40B — -6.1%
ACT Enact Holdings, Inc. $6.58B 10.6x 2.8%
ARX Accelerant Holdings $4.32B — 51.5%